Get early access! Join the Twelve Data AI Assistant waitlist now.
165.31000 USD
2.6
1.55%
Last update Oct 21, 3:59 PM EDT
Post-market
Day range
162.80000
167.88000
Previous close
167.91000
Open
166.89999
Access this stock data via API
Subscribe
Insmed Inc.
165.31
2.60
1.55%

Overview

Description

Insmed Inc. is a biopharmaceutical company dedicated to enhancing the lives of patients with rare diseases. The company's primary focus is on the development and commercialization of treatments for serious and rare disorders, particularly in the fields of pulmonology and infectious diseases. One of Insmed's noteworthy products is Arikayce, an inhaled antibiotic that addresses specific pulmonary infections often affecting patients with underlying lung conditions. Insmed Inc. also undertakes robust research and development efforts to boost its pipeline of potential therapies, aiming to address unmet medical needs. Operating within the broader healthcare sector, Insmed is a key player in the biopharmaceutical landscape, driven by innovation and scientific research. The company’s continued advancements and strategic collaborations underscore its commitment to elevating patient care and expanding treatment options for rare disease patients. This aligns Insmed as a significant entity in the realm of specialized healthcare solutions, reflecting its impact on the biopharmaceutical market.

About

CEO
Mr. William H. Lewis J.D., M.B.A.
Employees
1271
Address
700 US Highway 202/206
Bridgewater, 08807, NJ
United States
Phone
908 977 9900
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNGS
Post-market

Exchange is currently open for post-market.
Post market session closes in 1 hour 13 minutes

18:47
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).